March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
PCAB strengthens accreditation process
May 21st 2013The Pharmacy Compounding Accreditation Board will conduct unannounced surveys of compounding pharmacies seeking to renew accreditation from the group. The move is intended to further distinguish accredited compounding pharmacies from unaccredited ones.
Americans with chronic conditions add substantially to healthcare costs
May 15th 2013One-quarter of U.S. adults have multiple chronic conditions (MCC) and most suffer from a combination of diabetes, hypertension, and hyperlipidemia. Not surprisingly, medical expenses are significantly higher for those with MCC, according to a new study.